JCR Pharmaceuticals Co., Ltd.

JCRRFOTCHealthcare● Active

$4.25

+$1.11(+35.14%)

Market Cap$518468542

P/E Ratio—

52W High$5

52W Low$3.145

Avg Volume15

Open$4.25

Beta0.13

Overview

JCR Pharmaceuticals Co., Ltd. (JCRRF) Revenue

Annual & quarterly revenue history · segment & region breakdown

JCRRF · revenue · updated Jun 10, 2026

Core revenue metrics

Trailing 12 months

JCR Pharmaceuticals Co., Ltd. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue

$0.00B

4-quarter sum · USD

YoY growth

+0.00%

vs FY —

Price / sales

—

mktCap ÷ TTM rev

Revenue per day

—

Est. TTM ÷ 365

Revenue / employee

$0K

934 employees

—

5Y CAGR

—

Fiscal year end

Dec 31

Currency

USD · GAAP

Filing

10-K / 10-Q

Source: FMP · JCR Pharmaceuticals Co., Ltd. SEC filings · GAAPUpdated: 2026-06-10

Revenue trend

– · Annual

YoY revenue growth %

revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year end	Revenue	Change	Growth

JCRRF revenue by year · JCRRF revenue history · JCRRF annual revenue data

Compare revenue vs peers

Drug Manufacturers - General

Compare JCRRF revenue against listed peers. Click any row to open that company's revenue tab.

Glass House Brands Inc.

GLASF · $1.0B

→

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income JCR Pharmaceuticals Co., Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

JCR Pharmaceuticals Co., Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from JCR Pharmaceuticals Co., Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Price history Financial statements Forecast

Frequently asked questions

JCRRF revenue · 4 questions

JCRRF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

JCRRF revenueJCRRF annual revenuewhat is JCRRF revenueJCRRF TTM revenue

▸ Source: FMP · JCR Pharmaceuticals Co., Ltd. SEC filings · GAAP · JCR Pharmaceuticals Co., Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026